# Vaginal Estrogen for Asymptomatic Microscopic Hematuria

> **NCT03033160** · PHASE4 · UNKNOWN · sponsor: **Boston Urogynecology Associates** · enrollment: 68 (estimated)

## Conditions studied

- Asymptomatic Microscopic Hematuria

## Interventions

- **DRUG:** Estradiol Ring

## Key facts

- **NCT ID:** NCT03033160
- **Lead sponsor:** Boston Urogynecology Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2019-10
- **Final completion:** 2020-12-30
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2017-10-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033160, "Vaginal Estrogen for Asymptomatic Microscopic Hematuria". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03033160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*